• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨闪烁扫描术和正电子发射断层扫描术在药物相关性颌骨坏死早期诊断中的应用

Bone scintigraphy and positron emission tomography in the early diagnosis of MRONJ.

作者信息

Pergolini Daniele, Mohsen Mohamed, Tenore Gianluca, Palaia Gaspare, Magnifico Lorenzo, Del Vecchio Alessandro, Romeo Umberto

机构信息

Department of Oral and Maxillofacial Sciences, Sapienza University of Rome, Rome, Italy.

Department of Oral and Maxillofacial Sciences, Sapienza University of Rome, Via Caserta 6, 00161, Rome, Italy.

出版信息

Open Med (Wars). 2025 Feb 18;20(1):20251143. doi: 10.1515/med-2025-1143. eCollection 2025.

DOI:10.1515/med-2025-1143
PMID:39989613
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11843161/
Abstract

OBJECTIVES

The aim of this study is to evaluate the bone scintigraphy (BS) and positron emission tomography (PET) in the early diagnosis of medication-related osteonecrosis of the jaws (MRONJ) and their possible use in the identification of patients at risk for MRONJ.

MATERIAL AND METHODS

Thirty-one patients treated with ONJ-related drugs and who had undergone BS or PET for the evaluation of bone lesions were included in the study. The jaws of each patient were divided into four areas. For each area, the presence of pathological tracer uptake was evaluated and related to the eventual MRONJ development. Sensitivity, specificity, and predictive values of both techniques were determined. The latency from the finding of pathological tracer uptake in BS or PET to the clinical diagnosis of MRONJ and the odds ratio were also calculated.

RESULTS

Sensitivity and specificity of BS for MRONJ prediction were, respectively, 83.3 and 87.5%. Positive and negative predictive values were, respectively, 73.2 and 92.8%. The odds ratio was 35. Sensitivity of PET was 33.3%, specificity was 94.9%, and positive and negative predictive values were 70.0 and 80.0%, respectively. The odds ratio was 9.333. All values were statistically significant.

CONCLUSIONS

BS and PET may be accurate techniques for an early prediction of MRONJ.

摘要

目的

本研究旨在评估骨闪烁显像(BS)和正电子发射断层扫描(PET)在药物相关性颌骨坏死(MRONJ)早期诊断中的应用,以及它们在识别MRONJ高危患者方面的潜在用途。

材料与方法

本研究纳入了31例接受过与ONJ相关药物治疗且已接受BS或PET检查以评估骨病变的患者。将每位患者的颌骨分为四个区域。对于每个区域,评估病理性示踪剂摄取情况,并将其与最终的MRONJ发展情况相关联。确定了两种技术的敏感性、特异性和预测值。还计算了从BS或PET中发现病理性示踪剂摄取到MRONJ临床诊断的潜伏期以及比值比。

结果

BS预测MRONJ的敏感性和特异性分别为83.3%和87.5%。阳性和阴性预测值分别为73.2%和92.8%。比值比为35。PET的敏感性为33.3%,特异性为94.9%,阳性和阴性预测值分别为70.0%和80.0%。比值比为9.333。所有值均具有统计学意义。

结论

BS和PET可能是早期预测MRONJ的准确技术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/11843161/40d5d5fa6a48/j_med-2025-1143-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/11843161/784cc19e09ab/j_med-2025-1143-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/11843161/40d5d5fa6a48/j_med-2025-1143-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/11843161/784cc19e09ab/j_med-2025-1143-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/11843161/40d5d5fa6a48/j_med-2025-1143-fig002.jpg

相似文献

1
Bone scintigraphy and positron emission tomography in the early diagnosis of MRONJ.骨闪烁扫描术和正电子发射断层扫描术在药物相关性颌骨坏死早期诊断中的应用
Open Med (Wars). 2025 Feb 18;20(1):20251143. doi: 10.1515/med-2025-1143. eCollection 2025.
2
Bone scintigraphy predicts bisphosphonate-induced osteonecrosis of the jaw (BRONJ) in patients with metastatic castration-resistant prostate cancer (mCRPC).骨闪烁显像术可预测转移性去势抵抗性前列腺癌(mCRPC)患者双膦酸盐相关性颌骨坏死(BRONJ)。
Clin Oral Investig. 2016 May;20(4):753-8. doi: 10.1007/s00784-015-1563-8. Epub 2015 Aug 26.
3
Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (5), utility of bone scintigraphy and F-FDG PET/CT in early detection and risk assessment of medication-related osteonecrosis of the jaw (secondary publication).专题研讨会:颌骨药物相关性骨坏死的影像学检查方法(5),骨闪烁显像和F-FDG PET/CT在颌骨药物相关性骨坏死早期检测及风险评估中的应用(二次发表)
Jpn Dent Sci Rev. 2019 Nov;55(1):76-79. doi: 10.1016/j.jdsr.2018.12.002. Epub 2019 Mar 20.
4
Does Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography Facilitate Treatment of Medication-Related Osteonecrosis of the Jaw?氟脱氧葡萄糖正电子发射断层扫描联合计算机断层扫描是否有助于颌骨药物相关性骨坏死的治疗?
J Oral Maxillofac Surg. 2016 May;74(5):945-58. doi: 10.1016/j.joms.2015.10.025. Epub 2015 Nov 6.
5
Imaging modalities for drug-related osteonecrosis of the jaw (3), Positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw.颌骨药物相关性骨坏死的影像学检查方法(3),正电子发射断层扫描成像在颌骨药物相关性骨坏死诊断中的应用
Jpn Dent Sci Rev. 2019 Nov;55(1):65-70. doi: 10.1016/j.jdsr.2018.12.001. Epub 2019 Mar 15.
6
Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study.多发性骨髓瘤患者的影像学骨丢失与颌骨药物相关性骨坏死(MRONJ)风险——一项回顾性病例对照研究
Spec Care Dentist. 2018 Nov;38(6):356-361. doi: 10.1111/scd.12318. Epub 2018 Sep 8.
7
Preoperative Assessment of Medication-Related Osteonecrosis of the Jaw Using [18F]fluoride Positron Emission Tomography (PET)/CT and [18F]fluorodeoxyglucose PET/MRI in Correlation with Histomorphometry and Micro-CT-A Prospective Comparative Study.使用[18F]氟化物正电子发射断层扫描(PET)/CT和[18F]氟脱氧葡萄糖PET/MRI对颌骨药物相关性骨坏死进行术前评估,并与组织形态计量学和显微CT进行相关性分析:一项前瞻性比较研究
Diagnostics (Basel). 2024 Feb 15;14(4):428. doi: 10.3390/diagnostics14040428.
8
F-Fluoride PET/CT Imaging of Medication-Related Osteonecrosis of the Jaw in Conservative Treatment-A Case Report.氟-18氟化物PET/CT成像在颌骨药物相关性骨坏死保守治疗中的应用——病例报告
Front Oncol. 2021 Jul 1;11:700397. doi: 10.3389/fonc.2021.700397. eCollection 2021.
9
Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis.药物相关性颌骨坏死(MRONJ)的微观结构;回顾性 micro-CT 和形态计量分析。
J Craniomaxillofac Surg. 2021 Jun;49(6):508-517. doi: 10.1016/j.jcms.2021.02.018. Epub 2021 Mar 2.
10
Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ).牙种植体作为颌骨药物相关性骨坏死(MRONJ)患者的危险因素。
Br J Oral Maxillofac Surg. 2020 Sep;58(7):771-776. doi: 10.1016/j.bjoms.2020.03.022. Epub 2020 Jul 3.

本文引用的文献

1
Epidemiology, etiopathogenesis, and management of MRONJ: A European multicenter study.MRONJ 的流行病学、病因学和治疗:一项欧洲多中心研究。
J Stomatol Oral Maxillofac Surg. 2024 Sep;125(5S1):101931. doi: 10.1016/j.jormas.2024.101931. Epub 2024 May 29.
2
Italian position paper (SIPMO-SICMF) on medication-related osteonecrosis of the jaw (MRONJ).意大利关于药物相关性颌骨坏死 (MRONJ) 的立场文件 (SIPMO-SICMF)。
Oral Dis. 2024 Sep;30(6):3679-3709. doi: 10.1111/odi.14887. Epub 2024 Feb 5.
3
Accident due to Incorrect Selection of Diode Laser Technique in the Treatment of Oral Venous Malformation.
口腔静脉畸形治疗中因二极管激光技术选择不当导致的意外情况。
Case Rep Dent. 2023 Dec 8;2023:8817274. doi: 10.1155/2023/8817274. eCollection 2023.
4
American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update.美国口腔颌面外科学会关于药物相关性颌骨坏死的立场文件-2022 更新。
J Oral Maxillofac Surg. 2022 May;80(5):920-943. doi: 10.1016/j.joms.2022.02.008. Epub 2022 Feb 21.
5
Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020.药物相关性颌骨坏死 (MRONJ) 的预防和诊断:意大利 2020 年共识更新。
Int J Environ Res Public Health. 2020 Aug 18;17(16):5998. doi: 10.3390/ijerph17165998.
6
Does Medication-Related Osteonecrosis of the Jaw Influence the Quality of Life of Cancer Patients?药物相关性颌骨坏死会影响癌症患者的生活质量吗?
Biomedicines. 2020 Apr 24;8(4):95. doi: 10.3390/biomedicines8040095.
7
Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (5), utility of bone scintigraphy and F-FDG PET/CT in early detection and risk assessment of medication-related osteonecrosis of the jaw (secondary publication).专题研讨会:颌骨药物相关性骨坏死的影像学检查方法(5),骨闪烁显像和F-FDG PET/CT在颌骨药物相关性骨坏死早期检测及风险评估中的应用(二次发表)
Jpn Dent Sci Rev. 2019 Nov;55(1):76-79. doi: 10.1016/j.jdsr.2018.12.002. Epub 2019 Mar 20.
8
Imaging modalities for drug-related osteonecrosis of the jaw (3), Positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw.颌骨药物相关性骨坏死的影像学检查方法(3),正电子发射断层扫描成像在颌骨药物相关性骨坏死诊断中的应用
Jpn Dent Sci Rev. 2019 Nov;55(1):65-70. doi: 10.1016/j.jdsr.2018.12.001. Epub 2019 Mar 15.
9
Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (1), role of imaging in drug-related osteonecrosis of the jaw: An up-to-date review (secondary publication).专题研讨会:颌骨药物性骨坏死的影像学检查方法(1),影像学在颌骨药物性骨坏死中的作用:最新综述(二次发表)
Jpn Dent Sci Rev. 2019 Nov;55(1):1-4. doi: 10.1016/j.jdsr.2018.11.004. Epub 2019 Jan 17.
10
Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment.药物相关性颌骨坏死:预防、诊断和治疗的定义及最佳实践。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Feb;127(2):117-135. doi: 10.1016/j.oooo.2018.09.008. Epub 2018 Oct 9.